Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
198 | 3 | MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA | 52973 |
2395 | 2 | CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB | 4457 |
193 | 1 | CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB | 3995 |
29828 | 1 | REGORAFENIB//FRUQUINTINIB//N DESETHYL SUNITINIB | 196 |
31398 | 1 | AZILSARTAN//AZILSARTAN MEDOXOMIL//TAK 491 | 167 |
36401 | 1 | BIOL PHARM CLIN//ACCELERATED APPROVAL REGULATIONS//AG 1295 | 99 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CHRONIC MYELOID LEUKEMIA | authKW | 3137839 | 22% | 45% | 987 |
2 | IMATINIB | authKW | 2312691 | 20% | 37% | 885 |
3 | NILOTINIB | authKW | 1579933 | 7% | 70% | 321 |
4 | DASATINIB | authKW | 1379145 | 8% | 54% | 364 |
5 | BCR ABL | authKW | 1005301 | 10% | 33% | 436 |
6 | CML | authKW | 808288 | 9% | 28% | 409 |
7 | IMATINIB MESYLATE | authKW | 506031 | 5% | 31% | 231 |
8 | CHRONIC MYELOGENOUS LEUKEMIA | authKW | 449658 | 5% | 26% | 242 |
9 | IMATINIB RESISTANCE | authKW | 374116 | 2% | 61% | 87 |
10 | BCR ABL1 | authKW | 371735 | 2% | 56% | 94 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Hematology | 82805 | 41% | 1% | 1843 |
2 | Oncology | 25697 | 40% | 0% | 1779 |
3 | Pharmacology & Pharmacy | 1652 | 14% | 0% | 602 |
4 | Medicine, Research & Experimental | 291 | 4% | 0% | 190 |
5 | Biochemical Research Methods | 285 | 4% | 0% | 162 |
6 | Medical Laboratory Technology | 263 | 2% | 0% | 68 |
7 | Medicine, General & Internal | 236 | 5% | 0% | 228 |
8 | Chemistry, Analytical | 203 | 4% | 0% | 200 |
9 | Cell Biology | 121 | 5% | 0% | 217 |
10 | Chemistry, Medicinal | 119 | 2% | 0% | 104 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LEUKEMIA | 306447 | 8% | 13% | 335 |
2 | HEMATOL UNIT HELSINKI | 102610 | 1% | 52% | 28 |
3 | HEMATOL ONCOL LA SERAGNOLI | 93910 | 1% | 47% | 28 |
4 | HEMATOL | 87208 | 18% | 2% | 804 |
5 | MED UNIV KLIN 3 | 83680 | 1% | 39% | 30 |
6 | MED FAK MANNHEIM | 74512 | 2% | 15% | 69 |
7 | HEMATOPOIESE LEUCEM CIBLE THER EUT | 72711 | 0% | 86% | 12 |
8 | HEMATOL ONCOL L A SERAGNOLI | 68087 | 0% | 57% | 17 |
9 | PAUL OGORMAN LEUKAEMIA | 64409 | 1% | 33% | 28 |
10 | MED KLIN 3 | 61385 | 3% | 6% | 138 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 38744 | 2% | 8% | 68 |
2 | LEUKEMIA | 33970 | 4% | 3% | 193 |
3 | LEUKEMIA RESEARCH | 23779 | 3% | 2% | 144 |
4 | BLOOD | 22229 | 7% | 1% | 333 |
5 | LEUKEMIA & LYMPHOMA | 17714 | 3% | 2% | 140 |
6 | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 16461 | 1% | 4% | 64 |
7 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 16187 | 2% | 2% | 95 |
8 | CURRENT HEMATOLOGIC MALIGNANCY REPORTS | 15694 | 1% | 8% | 28 |
9 | CLINICAL LYMPHOMA & MYELOMA | 10552 | 0% | 7% | 22 |
10 | LATIN AMERICAN JOURNAL OF PHARMACY | 9203 | 1% | 2% | 59 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CHRONIC MYELOID LEUKEMIA | 3137839 | 22% | 45% | 987 | Search CHRONIC+MYELOID+LEUKEMIA | Search CHRONIC+MYELOID+LEUKEMIA |
2 | IMATINIB | 2312691 | 20% | 37% | 885 | Search IMATINIB | Search IMATINIB |
3 | NILOTINIB | 1579933 | 7% | 70% | 321 | Search NILOTINIB | Search NILOTINIB |
4 | DASATINIB | 1379145 | 8% | 54% | 364 | Search DASATINIB | Search DASATINIB |
5 | BCR ABL | 1005301 | 10% | 33% | 436 | Search BCR+ABL | Search BCR+ABL |
6 | CML | 808288 | 9% | 28% | 409 | Search CML | Search CML |
7 | IMATINIB MESYLATE | 506031 | 5% | 31% | 231 | Search IMATINIB+MESYLATE | Search IMATINIB+MESYLATE |
8 | CHRONIC MYELOGENOUS LEUKEMIA | 449658 | 5% | 26% | 242 | Search CHRONIC+MYELOGENOUS+LEUKEMIA | Search CHRONIC+MYELOGENOUS+LEUKEMIA |
9 | IMATINIB RESISTANCE | 374116 | 2% | 61% | 87 | Search IMATINIB+RESISTANCE | Search IMATINIB+RESISTANCE |
10 | BCR ABL1 | 371735 | 2% | 56% | 94 | Search BCR+ABL1 | Search BCR+ABL1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |